At a glance
ClinicalIndex Comparison RecordN/ACompleted· 90 enrolled
Drug / intervention
progesterone +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vaginal Progesterone Supplementation in the Management of Preterm Labor: A Randomized, Double Blind, Controlled Trial
In Brief
A clinical study evaluating progesterone, Tocolytics, and 1 other intervention for Preterm Labor. Completed, enrolled 90 participants across 1 site.
Detailed Summary
This study evaluates the addition of vaginal progesterone in the management of preterm labor. Half of participants will receive vaginal progesterone, tocolysis and corticosteroid, while the other half will receive only tocolysis and corticosteroid.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPreterm Labor
CountriesThailand
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartJun 2017
Primary CompletionJul 2018
Study CompletionJul 2018
TodayJul 2026
First PostedJun 29, 2017
Enrollment StartJun 29, 2017
Primary CompletionJul 30, 2018
Study CompletionJul 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.0 years ago
Interventions
progesteronedrug
vaginal utrogestan
Tocolyticsdrug
tocolysis for 48 hours
Steroidsdrug
antenatal corticosteroids for 48 hours